SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-20-004652
Filing Date
2020-04-29
Accepted
2020-04-29 17:19:49
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A cbmg_defa14a.htm DEFA14A 38121
2 IMAGE cbmg_defa14a000.jpg GRAPHIC 1168
3 IMAGE cbmg_defa14a001.jpg GRAPHIC 1032
4 IMAGE cbmg_defa14a002.jpg GRAPHIC 967
5 IMAGE cbmg_defa14a003.jpg GRAPHIC 1112
  Complete submission text file 0001654954-20-004652.txt   45787
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36498 | Film No.: 20831750
SIC: 2836 Biological Products, (No Diagnostic Substances)